Not Signed In -
Vaccine Safety Research |
|
|
Clinical Trial: Descriptive, Post-Marketing, Passive Surveillance Safety Study of ADACEL™ Vaccine
This study is not yet open for patient recruitment.
Verified by Sanofi-Aventis December 2005
|
Purpose
To further characterize the vaccine safety profile and to identify any signals of potentially vaccine-related AEs not detected during pre-licensure studies.
| Condition | Intervention | Phase |
|---|---|---|
| Pertussis | Vaccine: Tetanus Toxoid, acellular pertussis, diphtheria toxoid | Phase IV |
MedlinePlus related topics: Bacterial Infections; Bronchitis; Lung Diseases
Study Type: Observational
Study Design: Natural History, Longitudinal, Defined Population, Retrospective/Prospective Study
Further study details as provided by Sanofi-Aventis:
Study start: January 2006
Eligibility
Genders Eligible for Study: Both
Accepts Healthy Volunteers
Criteria
Location and Contact Information
Please refer to this study by ClinicalTrials.gov identifier NCT00258882
Public Registry Sanofi Pasteur RegistryContactUs@sanofipasteur.com
California
Oakland, California, United States
Colorado
Aurora, Colorado, United States
Oregon
Portland, Oregon, United States
Study chairs or principal investigators
Clinical Trials, Study Director, sanofi pasteur
More Information
Study ID Numbers: TD512
Last Updated: December 16, 2005
Record first received: November 24, 2005
ClinicalTrials.gov Identifier: NCT00258882
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2006-01-10
Last Updated: December 16, 2005
Record first received: November 24, 2005
ClinicalTrials.gov Identifier: NCT00258882
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2006-01-10
email this page
print this page
bookmark this page
feedback on this page
